Insider trade

Boston Scientific (BSX): Officer exercised options on 1,171 shares

Padraig Andrew O'connor, Officer at Boston Scientific, reported an option exercise of 1,171 shares.

1,171
Shares
Traded
Sep 2, 2026
Filed
Sep 3, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 4, 2025Federal contract · $601K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $601K obligated to date
  2. Dec 23, 2025Federal contract · $493K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $493K obligated to date
  3. Mar 27, 2026CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  4. Jun 4, 2026CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  5. Jul 16, 2026Federal contract · $608K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $608K obligated to date
  6. Jul 21, 2026Company filing · Form 8-K · RestructuringAnnounced job cuts, closures or a restructuring“On July 21, 2026, the Board of Directors of Boston Scientific Corporation (the “Company”) approved a new global restructuring program (the “2026 Restructuring Plan”).”
  7. Jul 29, 2026Company filing · Form 8-K · ResultsReported its results
  8. Jul 31, 2026InsiderDirector purchased ~$227K of BSX shares in the open market
  9. Aug 3, 2026Insider · 2 peopleInsiders: 2 purchases (~$9.1M)
  10. Aug 4, 2026Insider · 3 insiders in a week, 7th time since 2006Director purchased ~$6.8K of BSX shares in the open market
  11. Aug 5, 2026Insider · 3 insiders in a week, 7th time since 2006Director purchased ~$100K of BSX shares in the open market
  12. Aug 6, 20265% stakeFMR LLC reported a passive stake (13G) of 3.1%
  13. Aug 18, 2026CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  14. Aug 25, 2026Insider · 13 days before an 8-KDirector purchased ~$100K of BSX shares in the open market
  15. Aug 31, 2026CongressDisclosed sale of BSX — reported range $15,001 - $50,000

What came next

  1. Sep 3, 2026Congress · 1 personMembers of Congress: 3 sales
  2. Sep 4, 2026CongressDisclosed partial sale of BSX — reported range $50,001 - $100,000
  3. Sep 7, 2026Company filing · Form 8-K · Cyber incidentReported a cybersecurity incident“As previously disclosed in a Current Report on Form 8-K filed on August 26, 2026 with the Securities and Exchange Commission, on August 25, 2026, Boston Scientific Corporation (the “ Company ”) identified a cybersecurity incident that affected certain of its information technology systems and resulted in a global disruption to the Company’s operations.”
  4. Sep 9, 2026CongressDisclosed sale of BSX — reported range $50,001 - $100,000
  5. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/021/J/1RO/130; Material Number: M001195270
  6. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/027/BERN/1RO/130; Material Number: M001195440
  7. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/FATHOM/027/BERN/1RO/155; Material Number: M001195750
  8. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/TRANSEND/021/BERN/1RO/130; Material Number: M001195840
  9. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/027/SWAN/1RO/130; Material Number: M001195500
  10. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/021/SWAN/1RO/155; Material Number: M001195310
  11. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/FATHOM/021/BERN/1RO/130; Material Number: M001195640
  12. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/027/J/1RO/155; Material Number: M001195480
  13. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/021/STRAIGHT/2RO/155; Material Number: M001195330
  14. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/021/STRAIGHT/1RO/130; Material Number: M001195210
  15. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/021/J/1RO/155; Material Number: M001195280
  16. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/021/SWAN/1RO/130; Material Number: M001195300
  17. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/021/BERN/1RO/105; Material Number: M001195230
  18. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/FATHOM/021/BERN/2RO/130; Material Number: M001195670
  19. Sep 21, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 21, 2026, Arthur C. Butcher informed Boston Scientific Corporation (the “Company”) that he has decided to retire from his role as Executive Vice President and Group President, MedSurg and Asia Pacific effective as of January 1, 2027.”
  20. Sep 30, 2026FDARecall: Nalu TD2 Therapy Disc with firmware, REF: 34014-001, and TD2 Patient Kit, REF: 74011, part of the Nalu Neurostimulation System
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Boston Scientific

For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.

How this filing works

Explore the data

Common questions

Which Boston Scientific (BSX) insider traded, and how much?

Padraig Andrew O'connor, Officer at Boston Scientific, reported an option exercise of 1,171 shares. Not an open-market trade.

When did it happen, and when was it made public?

Traded: Sep 2, 2026. Filed: Sep 3, 2026. That is 1 day between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Boston Scientific recently?

For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days. They are listed on the BSX page.

Does this mean BSX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Boston Scientific

Everything OQRO holds on this company is on its BSX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data